Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed to reduce interference in an optical fiber, supporting more stable and consistent measurement data throughout monitoring. Patent applications are pending in the U.S. and Europe.
“This Chinese patent expands our IP protection within a new patent family and strengthens our international position. The invention contributes to optimizing the Neola® system for continuous lung monitoring, helping to support consistent measurement quality,” says CEO Hanna Sjöström.
About the patent
The granted patent belongs to Neola Medical’s patent family “A device for smoothing spectral transmission modulations and a method thereof” and protects the company’s innovation for optimizing measurement data by reducing interference in the optical fiber during lung monitoring.